1.Combined first trimester screen or noninvasive prenatal testing or both.
Singapore medical journal 2015;56(1):1-3
Chorionic Gonadotropin, beta Subunit, Human
;
blood
;
Cost-Benefit Analysis
;
Down Syndrome
;
blood
;
diagnosis
;
False Positive Reactions
;
Female
;
Health Care Costs
;
Humans
;
Maternal Serum Screening Tests
;
economics
;
methods
;
standards
;
Pregnancy
;
Pregnancy Trimester, First
;
blood
;
Pregnancy-Associated Plasma Protein-A
;
metabolism
;
Prenatal Care
;
methods
;
Prenatal Diagnosis
;
economics
;
methods
;
standards